Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Not applicableLooking for participantsNCT06279676
What this trial is testing

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

Who this might be right for
GVHD, Chronic
Ciusss de L'Est de l'Île de Montréal 100
Testing effectiveness (Phase 2)WithdrawnNCT01812720
What this trial is testing

Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Not applicableStudy completedNCT03233659
What this trial is testing

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell TransplantationGVHD
IRCCS Azienda Ospedaliero-Universitaria di Bologna 177
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Testing effectiveness (Phase 2)Study completedNCT00734396
What this trial is testing

Mesenchymal Stem Cells and Subclinical Rejection

Who this might be right for
Organ Transplantation
Leiden University Medical Center 15
Not applicableStudy completedNCT02867891
What this trial is testing

Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Who this might be right for
Acute Myeloid Leukemia
Robert Zeiser 396
Testing effectiveness (Phase 2)Study completedNCT01352286
What this trial is testing

Redirected Auto T Cells for Advanced Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07737262
What this trial is testing

Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients

Who this might be right for
Aplastic Anemia
Peking University People's Hospital 142
Not applicableEnded earlyNCT03752372
What this trial is testing

Microbiome Alterations in IL10RA-deficient Patients After HSCT

Who this might be right for
Inflammatory Bowel DiseasesMicrobiota
Children's Hospital of Fudan University 13
Large-scale testing (Phase 3)Looking for participantsNCT07047456
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Who this might be right for
Acute Graft Versus Host Disease
Anhui Provincial Hospital 134
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Not applicableUnknownNCT05218603
What this trial is testing

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Who this might be right for
Multiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT)
PETHEMA Foundation 100
Testing effectiveness (Phase 2)Study completedNCT00310037
What this trial is testing

Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology 151
Testing effectiveness (Phase 2)Study completedNCT02017457
What this trial is testing

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Carlos Graux, MD, PhD 50
Testing effectiveness (Phase 2)Study completedNCT01570283
What this trial is testing

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

Who this might be right for
Viral Infection
AlloVir 21
Next Page